Art Therapy in Progressive Supranuclear Palsy
Launched by VANDERBILT UNIVERSITY MEDICAL CENTER · Sep 6, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how art therapy can help people with Progressive Supranuclear Palsy (PSP), a condition that affects movement and balance. The study aims to see if engaging in art activities can reduce symptoms of PSP, improve the quality of life for patients, and lessen the stress that caregivers often experience. By participating in this trial, individuals with PSP may find new ways to express themselves and enjoy life more fully.
To be eligible for this study, participants must have a diagnosis of PSP and be able to understand and agree to take part in the trial. Unfortunately, those with other neurological conditions or significant cognitive challenges that prevent them from providing consent won't be able to participate. If you join the study, you can expect to participate in art therapy sessions designed specifically for your needs, helping both you and your caregivers in the process. This is an exciting opportunity to explore the potential benefits of art in managing PSP and enhancing overall well-being.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosis of progressive supranuclear palsy
- • Have the cognitive ability to provide informed consent
- Exclusion Criteria:
- • Primary neurological diagnosis other than progressive supranuclear palsy
- • Cognition too impaired to provide informed consent
About Vanderbilt University Medical Center
Vanderbilt University Medical Center (VUMC) is a leading academic medical center located in Nashville, Tennessee, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, VUMC integrates cutting-edge scientific inquiry with patient-centered care, supporting a diverse array of studies aimed at enhancing medical knowledge and improving treatment outcomes. With a robust infrastructure and a multidisciplinary team of experts, VUMC fosters collaboration across various fields, ensuring the highest standards of safety and ethical considerations in its research endeavors. Through its dedication to medical discovery and education, VUMC plays a pivotal role in shaping the future of medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nashville, Tennessee, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported